A new vaccine policy has been announced, allowing boosters for high-risk patients while leaving healthy adults and children in a gray area. Experts warn this could lead to fewer vaccinations and rising COVID-19 cases.
In a major shift, the FDA has approved updated Covid boosters while restricting access for children under 5, raising concerns among parents and health experts. Learn about the new guidelines and their implications.
The FDA has updated warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, especially for young men. Learn what the new labels say and what it means for vaccine safety.
Pfizer Inc. has decided to stop the development of its obesity pill, danuglipron, after safety concerns emerged from a clinical trial. This move comes as competition heats up with Novo Nordisk and Eli Lilly's successful weight-loss treatments.
A recent study reveals that Paxlovid, Pfizer's antiviral treatment for COVID-19, may not significantly reduce hospitalizations or deaths in vaccinated older adults. Researchers express surprise at the findings, urging caution in treatment decisions for this demographic.
